GGrantIndex
← Leaderboards

Alan L Rothman

University Of Rhode Island

$27,777,946
Attributed
$27,777,946
Total exposure
22
Grants
21
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $8M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$76,116,755 · 25

By mechanism

P01$44,087,003 · 14
P20$14,270,738 · 2
U19$9,158,703 · 4
U01$7,301,487 · 3
T32$868,637 · 1
R21$430,187 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Programs

Research focus

ProgramsDengue VirusPathogenesisFlavivirus InfectionsDenguePreventionInfectionCommunitiesNational Institute Of Allergy And Infectious DiseaseVirus DiseasesPlayImmune ResponseData ManagementVaccinesImmunityAcuteImmunologicsLaboratoriesBaseResearch PersonnelFundingVaccine DevelopmentAntibodiesOperation

Grant awards (97)

Long-term durability of DENV-specific immunity after vaccination in a dengue-endemic population$567,169
U01 · FY2025 · AI · contact PI
Long-term durability of DENV-specific immunity after vaccination in a dengue-endemic population$567,169
U01 · FY2024 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1,896,069
P01 · FY2022 · AI · contact PI
Core-002$920,251
P01 · FY2022 · AI · contact PI
Project-002$606,024
P01 · FY2022 · AI · contact PI
Core-001$233,413
P01 · FY2022 · AI · contact PI
Admin-Core-001$136,381
P01 · FY2022 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1,896,069
P01 · FY2021 · AI · contact PI
Project 3: Immunologic Determinants of Outcome in Dengue Virus Infection and Vaccination$511,266
P01 · FY2021 · AI · contact PI
Elimination of flavivirus infected target cells by ADCC$196,562
R21 · FY2021 · AI · contact PI
Core A: Administration$115,453
P01 · FY2021 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1,892,293
P01 · FY2020 · AI · contact PI
Project 3: Immunologic Determinants of Outcome in Dengue Virus Infection and Vaccination$511,265
P01 · FY2020 · AI · contact PI
Elimination of flavivirus infected target cells by ADCC$233,625
R21 · FY2020 · AI · contact PI
Core A: Administration$115,450
P01 · FY2020 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1,890,839
P01 · FY2019 · AI · contact PI
Project 3: Immunologic Determinants of Outcome in Dengue Virus Infection and Vaccination$511,283
P01 · FY2019 · AI · contact PI
Core A: Administration$115,479
P01 · FY2019 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1,900,000
P01 · FY2018 · AI · contact PI
Project 3: Immunologic Determinants of Outcome in Dengue Virus Infection and Vaccination$522,015
P01 · FY2018 · AI · contact PI
Core A: Administration$128,800
P01 · FY2018 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,249,648
P01 · FY2017 · AI · contact PI
Immune-Based Interventions Against Infectious Diseases$1,855,730
P20 · FY2017 · GM · contact PI
Administrative Core$825,785
P20 · FY2017 · GM · contact PI
Immunologic Determinants of Dengue Infection Outcome$506,016
P01 · FY2017 · AI · contact PI
Administrative Core$119,415
P01 · FY2017 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,249,648
P01 · FY2016 · AI · contact PI
Immune-Based Interventions Against Infectious Diseases$1,857,688
P20 · FY2016 · GM · contact PI
Administrative Core$826,958
P20 · FY2016 · GM · contact PI
Immunologic Determinants of Dengue Infection Outcome$531,271
P01 · FY2016 · AI · contact PI
Administrative Core$96,131
P01 · FY2016 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,249,299
P01 · FY2015 · AI · contact PI
Immune-Based Interventions Against Infectious Diseases$1,857,725
P20 · FY2015 · GM · contact PI
Administrative Core$825,805
P20 · FY2015 · GM · contact PI
Immunologic Determinants of Dengue Infection Outcome$534,004
P01 · FY2015 · AI · contact PI
Administrative Core$121,947
P01 · FY2015 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,248,902
P01 · FY2014 · AI · contact PI
Immune-Based Interventions Against Infectious Diseases$1,864,358
P20 · FY2014 · GM · contact PI
Administrative Core$829,585
P20 · FY2014 · GM · contact PI
Immunologic Determinants of Dengue Infection Outcome$505,996
P01 · FY2014 · AI · contact PI
Administrative Core$119,402
P01 · FY2014 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,411,226
P01 · FY2013 · AI · contact PI
Immune-Based Interventions Against Infectious Diseases$2,390,922
P20 · FY2013 · GM · contact PI
Administrative Core$1,136,182
P20 · FY2013 · GM · contact PI
Immunologic Determinants of Dengue Infection Outcome$543,530
P01 · FY2013 · AI · contact PI
Pilot Projects Core$169,112
U19 · FY2013 · AI · contact PI
Administrative Core$126,619
P01 · FY2013 · AI · contact PI
Administrative Core$101,176
U19 · FY2013 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1,985,380
P01 · FY2012 · AI · contact PI
Molecular Immunopathogenesis of DHF/DSS$345,970
P01 · FY2012 · AI · contact PI
Pilot Projects Core$290,891
U19 · FY2012 · AI · contact PI
Administrative$149,860
P01 · FY2012 · AI · contact PI
Administrative Core$112,671
U19 · FY2012 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,094,472
P01 · FY2011 · AI · contact PI
Molecular Immunopathogenesis of DHF/DSS$382,599
P01 · FY2011 · AI · contact PI
Pilot Projects Core$226,707
U19 · FY2011 · AI · contact PI
Administrative$224,071
P01 · FY2011 · AI · contact PI
Administrative Core$212,665
U19 · FY2011 · AI · contact PI
Administrative$1
P01 · FY2011 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$1
P01 · FY2011 · AI · contact PI
Cellular Immunity to Category A-C Viruses in Humans$3,237,810
U19 · FY2010 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,236,376
P01 · FY2010 · AI · contact PI
Molecular Immunopathogenesis of DHF/DSS$425,960
P01 · FY2010 · AI · contact PI
Automated point-of-care PCR for hemorrhagic fever diagnosis$420,840
U01 · FY2010 · AI · contact PI
Human T Cell Memory to Viruses$336,823
P01 · FY2010 · AI · contact PI
Administrative$292,616
P01 · FY2010 · AI · contact PI
Pilot Projects Core$228,663
U19 · FY2010 · AI · contact PI
Administrative Core$214,484
U19 · FY2010 · AI · contact PI
Automated point-of-care PCR for hemorrhagic fever diagnosis$184,250
U01 · FY2010 · AI · contact PI
Cellular Immunity to Category A-C Viruses in Humans$3,639,795
U19 · FY2009 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,208,691
P01 · FY2009 · AI · contact PI
Automated point-of-care PCR for hemorrhagic fever diagnosis$574,386
U01 · FY2009 · AI · contact PI
Molecular Immunopathogenesis of DHF/DSS$419,523
P01 · FY2009 · AI · contact PI
Human T Cell Memory to Viruses$333,460
P01 · FY2009 · AI · contact PI
Administrative$289,641
P01 · FY2009 · AI · contact PI
Pilot Projects Core$257,311
U19 · FY2009 · AI · contact PI
Administrative Core$241,400
U19 · FY2009 · AI · contact PI
Flavivirus Infections: Pathogenesis and Prevention$2,225,868
P01 · FY2008 · AI · contact PI
Automated point-of-care PCR for hemorrhagic fever diagnosis$780,426
U01 · FY2008 · AI · contact PI
Molecular Immunopathogenesis of DHF/DSS$423,209
P01 · FY2008 · AI · contact PI
Human T Cell Memory to Viruses$325,154
P01 · FY2008 · AI · contact PI
Administrative$297,248
P01 · FY2008 · AI · contact PI
Pilot Project Component$226,018
U19 · FY2008 · AI · contact PI
Virus Infections: Pathogenesis and Host Immune Responses$193,925
T32 · FY2008 · AI · contact PI
Automated point-of-care PCR for hemorrhagic fever diagnosis$983,643
U01 · FY2007 · AI · contact PI
Human T Cell Memory to Viruses$286,954
P01 · FY2007 · AI · contact PI
Virus Infections: Pathogenesis and Host Immune Responses$225,615
T32 · FY2007 · AI · contact PI
Automated point-of-care PCR for hemorrhagic fever diagnosis$873,862
U01 · FY2006 · AI · contact PI
Human T Cell Memory to Viruses$287,722
P01 · FY2006 · AI · contact PI
Virus Infections: Pathogenesis and Host Immune Responses$225,417
T32 · FY2006 · AI · contact PI
Virus Infections: Pathogenesis and Host Immune Responses$223,680
T32 · FY2005 · AI
PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELA$618,245
U01 · FY2004 · AI
PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELA$380,815
U01 · FY2003 · AI
PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELA$293,646
U01 · FY2003 · AI
PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELA$349,582
U01 · FY2002 · AI
PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELA$358,955
U01 · FY2001 · AI
PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELA$348,499
U01 · FY2000 · AI